126 related articles for article (PubMed ID: 9011688)
1. Tirofiban provides "platelet anesthesia" during cardiopulmonary bypass in baboons.
Hiramatsu Y; Gikakis N; Anderson HL; Gorman JH; Marcinkiewicz C; Gould RJ; Niewiarowski S; Edmunds LH
J Thorac Cardiovasc Surg; 1997 Jan; 113(1):182-93. PubMed ID: 9011688
[TBL] [Abstract][Full Text] [Related]
2. Glycoprotein IIb/IIIa receptor antagonist tirofiban inhibits thrombin generation during cardiopulmonary bypass in baboons.
Rao AK; Sun L; Hiramatsu Y; Gorman JH; Edmunds LH
Thromb Haemost; 1999 Jul; 82(1):140-4. PubMed ID: 10456468
[TBL] [Abstract][Full Text] [Related]
3. Integrilin prevents prolonged bleeding times after cardiopulmonary bypass.
Suzuki Y; Hillyer P; Miyamoto S; Niewiarowski S; Sun L; Rao AK; Hollenbach S; Edmunds LH
Ann Thorac Surg; 1998 Aug; 66(2):373-81. PubMed ID: 9725372
[TBL] [Abstract][Full Text] [Related]
4. Platelet anesthesia with nitric oxide with or without eptifibatide during cardiopulmonary bypass in baboons.
Suzuki Y; Malekan R; Hanson CW; Niewiarowski S; Sun L; Rao AK; Edmunds LH
J Thorac Cardiovasc Surg; 1999 May; 117(5):987-93. PubMed ID: 10220694
[TBL] [Abstract][Full Text] [Related]
5. Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting.
Bizzarri F; Scolletta S; Tucci E; Lucidi M; Davoli G; Toscano T; Neri E; Muzzi L; Frati G
J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1181-5. PubMed ID: 11726894
[TBL] [Abstract][Full Text] [Related]
6. Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade.
Durand M; Lecompte T; Hacquard M; Carteaux JP
Eur J Cardiothorac Surg; 2008 Sep; 34(3):687-9. PubMed ID: 18579401
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban.
Koster A; Kukucka M; Bach F; Meyer O; Fischer T; Mertzlufft F; Loebe M; Hetzer R; Kuppe H
Anesthesiology; 2001 Feb; 94(2):245-51. PubMed ID: 11176088
[TBL] [Abstract][Full Text] [Related]
8. Enhancement by ticlopidine of the inhibitory effect on in vitro platelet aggregation of the glycoprotein IIb/IIIa inhibitor tirofiban.
Umemura K; Kondo K; Ikeda Y; Nakashima M
Thromb Haemost; 1997 Nov; 78(5):1381-4. PubMed ID: 9408023
[TBL] [Abstract][Full Text] [Related]
9. Platelet preservation with a glycoprotein IIb/IIIa inhibitor in a porcine cardiopulmonary bypass model.
Kondo N; Suzuki Y; Wakayama F; Tamai Y; Ji K; Fukui K; Fukuda I
Ann Thorac Surg; 2005 Jul; 80(1):251-7. PubMed ID: 15975376
[TBL] [Abstract][Full Text] [Related]
10. Tirofiban. A review of its use in acute coronary syndromes.
McClellan KJ; Goa KL
Drugs; 1998 Dec; 56(6):1067-80. PubMed ID: 9878994
[TBL] [Abstract][Full Text] [Related]
11. [Use of heparin and platelet GPIIbIIIa inhibitor tirofiban for cardiac surgery in patients for suspicion of heparin-induced thrombocytopenia].
Commin PL; Rozec B; Trossaërt M; Le Teurnier Y; Fournet X; Blanloeil Y
Ann Fr Anesth Reanim; 2006; 25(11-12):1153-7. PubMed ID: 17174215
[TBL] [Abstract][Full Text] [Related]
12. One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II.
Koster A; Meyer O; Fischer T; Kukucka M; Krabatsch T; Bauer M; Kuppe H; Hetzer R
J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1254-5. PubMed ID: 11726910
[No Abstract] [Full Text] [Related]
13. Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant.
Koster A; Loebe M; Mertzlufft F; Kuppe H; Hetzer R
Ann Thorac Surg; 2000 Dec; 70(6):2160-1. PubMed ID: 11156147
[TBL] [Abstract][Full Text] [Related]
14. Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score.
Hermanides RS; Ottervanger JP; ten Berg JM; Gosselink AT; van Houwelingen G; Dambrink JH; Stella PR; Hamm C; van 't Hof AW;
J Invasive Cardiol; 2012 Mar; 24(3):84-9. PubMed ID: 22388296
[TBL] [Abstract][Full Text] [Related]
15. Ro 44-9883, a new nonpeptide glycoprotein IIb/IIIa antagonist, prevents platelet loss during experimental cardiopulmonary bypass.
Carteaux JP; Roux S; Kuhn H; Tschopp T; Colombo V; Hadváry P
J Thorac Cardiovasc Surg; 1993 Nov; 106(5):834-41. PubMed ID: 8231205
[TBL] [Abstract][Full Text] [Related]
16. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
[TBL] [Abstract][Full Text] [Related]
17. Enoxaparin suppresses thrombin formation and activity during cardiopulmonary bypass in baboons.
Gikakis N; Rao AK; Miyamoto S; Gorman JH; Khan MM; Anderson HL; Hack CE; Sun L; Niewiarowski S; Colman RW; Edmunds LH
J Thorac Cardiovasc Surg; 1998 Dec; 116(6):1043-51. PubMed ID: 9832697
[TBL] [Abstract][Full Text] [Related]
18. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
Coppe D; Sobel M; Seamans L; Levine F; Salzman E
J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
[TBL] [Abstract][Full Text] [Related]
19. Management of heparin resistance during cardiopulmonary bypass: the effect of five different anticoagulation strategies on hemostatic activation.
Koster A; Fischer T; Gruendel M; Mappes A; Kuebler WM; Bauer M; Kuppe H
J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):171-5. PubMed ID: 12698397
[TBL] [Abstract][Full Text] [Related]
20. Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass.
Shigeta O; Kojima H; Hiramatsu Y; Jikuya T; Terada Y; Atsumi N; Sakakibara Y; Nagasawa T; Mitsui T
J Thorac Cardiovasc Surg; 1999 Aug; 118(2):354-60. PubMed ID: 10425010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
